ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,489, issued on Dec. 23, was assigned to GLENMARK PHARMACEUTICALS Ltd. (Mumbai, India).
"Metered dose inhaler for ipratropium bromide solution" was invented by Ulhas Dhuppad (Maharashtra, India), Raveendra Pai (Maharashtra, India), Michael Crick (Glen Rock, N.J.), Ashok Katkurwar (Maharashtra, India), Jitendra Patil (Maharashtra, India), Rakshit Trivedi (Maharashtra, India) and Ramakant Chanagare (Maharashtra, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actua...